Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 191 to 200 of 249 resources
-
NHS Atlas of Variation in Healthcare for People with Liver Disease
Resource from NHS Liver Care providing area-specific data on liver disease in England.
UK Mar 2013 Reports & Research PDF -
Caring for people with liver disease: a competence framework for nursing
This resource from the Royal College of Nursing sets out the professional standards required for nurses to provide quality liver care and improve outcomes.
England Feb 2013 Reports & Research PDF -
Health Protection Report, Vol. 7 No.4
This January 2013 edition of the Health Protection Agency weekly report provides laboratory reports of hepatitis A and C cases in England and Wales, and data from the sentinel surveillance study of hepatitis testing in England, between July and September 2012.England, Wales 25 Jan 2013 Reports & Research PDF -
Hepatitis C: A projection of the healthcare and economic burden in the UK
Hepatitis C is a leading cause of chronic liver disease, end-stage cirrhosis and liver cancer, with the UK lagging behind a number of European countries in disease detection and treatment. This study sought to contribute to better understanding of the burden associated with HCV infection in the UK through estimating prevalence and number of deaths attributable to HCV infection, and by assessing the associated healthcare and societal costs.UK 2013 Reports & Research PDF -
Hepatitis B and C: ways to promote and offer testing. Practice-based implementation advice for commissioners, service leads and others providing training for professionals
This implementation advice accompanies the NICE public health guidance (available online at: www.nice.org.uk/guidance/PH43). It draws from the learning and experience of others to provide support for users who may wish to develop an action plan to implement certain aspects of the guidance. It is not NICE guidance. Professionals responsible for implementing the recommendations in the guidance may find this document useful. This document includes example pathways and signposts to resources from other organisations that may help.England Dec 2012 Reports & Research, Strategy & Planning MS Word -
Bridging the gap: Why some people are not offered the medicines that NICE recommends
The extent of variation in the uptake of NICE recommended medicines across the NHS in England has been described before. The reasons for such variations are less well understood. IMS Health conducted a qualitative study during the summer and autumn of 2012 to help investigate the reasons for that variation. Eight therapy areas were discussed during interviews with experts, including hepatitis C (HCV).England Nov 2012 Reports & Research PDF -
Shooting Up: Infections among people who inject drugs in the UK 2011. An update: November 2012
People who inject drugs (PWID) are vulnerable to a wide range of viral and bacterial infections. These infections can result in high levels of illness and in death, so public health surveillance of infectious diseases and the associated risk and protective behaviours among this group are important. This report describes time trends on the extent of infections among PWID in the UK to the end of 2011. This year’s report focuses on hepatitis B virus infection but also contains updates on hepatitis C, HIV and bacterial infections.UK Nov 2012 Reports & Research PDF -
Hepatitis C Testing and Treatment in Wirral. Increasing Treatment Places: A Practical Solution
The following report describes the practical steps taken by the local partnership in Wirral in the wake of the Department of Health’s 2002 publication of the ‘Hepatitis C Strategy for England: Getting Ahead of the Curve’, aimed at systematically increasing hepatitis C awareness and testing in Wirral in such a way as to increase demand for treatment places. In doing so, the partnership hoped to tangibly reduce local hepatitis C prevalence and the associated burden of treatment in the longer term.North West Oct 2012 Reports & Research PDF -
Burden of Liver Disease and Inequalities in the North West of England
This report presents data on liver disease in the North West of England, describing the burden by age, sex, deprivation and geography. It explores routinely available data for the main causes of liver disease; alcohol, hepatitis B and C and fatty liver disease. It is a useful resource for Directors of Public Health, health and wellbeing boards, commissioners and providers of services and others involved in liver disease.North West Sep 2012 Reports & Research PDF -
Increasing hepatitis B and C testing in the prison setting: The use of new diagnostics at HMP Manchester
Hepatitis B and C pose a major challenge to public health in the UK. Up to half a million people have one or both of these viruses, which can cause liver failure and cancer, yet only a minority have been diagnosed. Prevalence is particularly high in the prison population; evenNorth West Sep 2012 Case study, Reports & Research, Strategy & Planning PDF